We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+8.64%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$622B
AUM Growth
+$11.2B
Cap. Flow
-$16.1B
Cap. Flow %
-2.59%
Top 10 Hldgs %
26.59%
Holding
3,066
New
113
Increased
1,569
Reduced
1,081
Closed
107

Top Buys

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$1.6B
2
VZ icon
Verizon
VZ
+$1.3B
3
USB icon
US Bancorp
USB
+$1.26B
4
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$1.26B
5
LRCX icon
Lam Research
LRCX
+$1.18B

Sector Composition

Rank Sector Weight
1 Technology 26.7%
2 Healthcare 19.64%
3 Financials 12.71%
4 Consumer Discretionary 10.95%
5 Communication Services 7.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JRVR icon
2376
James River Group Holdings
JRVR
$199M
$291K ﹤0.01%
13,924
+548
+4% +$12.6K
RYZ
2377
Ryerson Holding Corp
RYZ
$1.5B
$290K ﹤0.01%
+9,577
New +$284K
JELD icon
2378
JELD-WEN Holding
JELD
$164M
$289K ﹤0.01%
29,980
+1,196
+4% +$11.6K
VERV
2379
DELISTED
Verve Therapeutics
VERV
$286K ﹤0.01%
14,805
-450
-3% -$11.9K
XOMA
2380
DELISTED
Xoma
XOMA
$286K ﹤0.01%
15,534
ARQT icon
2381
Arcutis Biotherapeutics
ARQT
$3.3B
$285K ﹤0.01%
19,246
-160,048
-89% -$2.8M
PNT
2382
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$285K ﹤0.01%
39,055
-10,920
-22% -$81K
HIFS icon
2383
Hingham Institution for Saving
HIFS
$689M
$284K ﹤0.01%
1,029
-10
-1% -$2.63K
PRTS icon
2384
CarParts.com
PRTS
$48.7M
$284K ﹤0.01%
4,538
-674
-13% -$35.3K
CVGI icon
2385
Commercial Vehicle Group
CVGI
$128M
$283K ﹤0.01%
41,600
FOR icon
2386
Forestar Group
FOR
$1.49B
$283K ﹤0.01%
18,397
KURA icon
2387
Kura Oncology
KURA
$882M
$283K ﹤0.01%
22,785
-3,963
-15% -$57.6K
USNA icon
2388
Usana Health Sciences
USNA
$250M
$282K ﹤0.01%
5,307
+205
+4% +$11.1K
IVT icon
2389
InvenTrust Properties
IVT
$2.59B
$280K ﹤0.01%
11,845
+905
+8% +$21.6K
LL
2390
DELISTED
LL Flooring Holdings, Inc.
LL
$279K ﹤0.01%
49,591
+16,450
+50% +$115K
TDAY
2391
USA Today Co
TDAY
$1.01B
$276K ﹤0.01%
136,099
+15,103
+12% +$29K
GLRE icon
2392
Greenlight Captial
GLRE
$505M
$276K ﹤0.01%
33,844
RUTH
2393
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
$276K ﹤0.01%
17,854
+481
+3% +$8.45K
HYLN icon
2394
Hyliion Holdings
HYLN
$734M
$274K ﹤0.01%
116,937
+3,531
+3% +$9.59K
MVST icon
2395
Microvast
MVST
$341M
$274K ﹤0.01%
179,322
+34,214
+24% +$69.7K
CHS
2396
DELISTED
Chicos FAS, Inc.
CHS
$274K ﹤0.01%
55,600
+2,676
+5% +$15K
PGEN icon
2397
Precigen
PGEN
$2.32B
$272K ﹤0.01%
178,734
VRA icon
2398
Vera Bradley
VRA
$96.7M
$272K ﹤0.01%
60,100
CVLG icon
2399
Covenant Logistics
CVLG
$865M
$271K ﹤0.01%
15,692
AAIC
2400
DELISTED
Arlington Asset Investment Corp.
AAIC
$270K ﹤0.01%
92,100

Similar funds

T. Rowe Price Associates's Q4 2022 Portfolio in Review

As of Q4 2022, T. Rowe Price Associates held 3,066 positions worth $622B, up 1.8% from $610B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

T. Rowe Price Associates's Q4 2022 filing shows 113 new, 1,569 increased, 1,081 reduced and 107 closed positions. Its largest new stake was GE HealthCare: 6,360,001 shares worth $371M. The largest sale was Amazon, an estimated $6.33B.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.

  • T. Rowe Price Associates's largest Q4 2022 buy was GE HealthCare: 6,360,001 shares worth $371M.
  • T. Rowe Price Associates added most to JPMorgan Chase in Q4 2022, an estimated $1.6B increase.
  • T. Rowe Price Associates's biggest Q4 2022 reduction was Amazon, cutting an estimated $6.33B.
  • T. Rowe Price Associates fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $3.44B.
  • T. Rowe Price Associates's ten largest holdings make up 27% of its $622B portfolio in Q4 2022.
  • T. Rowe Price Associates opened 113 new positions and closed 107 in Q4 2022.
  • T. Rowe Price Associates's portfolio value rose 1.8% quarter-over-quarter to $622B.

Based on T. Rowe Price Associates's 13F filing for Q4 2022, filed 14 Feb 2023.